← Back to Clinical Trials
Recruiting NCT07191184

NCT07191184 Identification of Obstacles and Levers to the Outpatient Care of Patients in Terminal Palliative Situations

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07191184
Status Recruiting
Phase
Sponsor University Hospital, Strasbourg, France
Condition End of Life
Study Type OBSERVATIONAL
Enrollment 12 participants
Start Date 2024-09-16
Primary Completion 2025-12-16

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 12 participants in total. It began in 2024-09-16 with a primary completion date of 2025-12-16.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

80% of patients wish to die at home. The number of deaths will increase in the coming years due to the aging population. The general practitioner (GP) is at the center of this care. Despite national plans for the development of palliative care, dying at home remains complicated. The difficulties described and known are organizational (workload) and linked to the doctor's experience with the suffering of the patient and their family. Many studies have been conducted in hospital settings, and the solutions developed are often not very accessible to GP. Conducting a study on this subject will allow us to take stock of this outpatient care provided by general practitioners following numerous changes that have occurred in recent years, both in terms of palliative care teaching and in terms of modifications to the care offered.

Eligibility Criteria

Inclusion Criteria: * General physician based in Bas-Rhin * Agreeing to participate in the research Exclusion Criteria: * Refusing to participate in the research * Replacement physician, specialist physician, based outside Bas-Rhin

Contact & Investigator

Central Contact

Catherine CHEVALIER-LAMOUILLE, MD

✉ catherine.lamouille@chru-strasbourg.fr

📞 33 3 88 11 65 86

Frequently Asked Questions

Who can join the NCT07191184 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying End of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07191184 currently recruiting?

Yes, NCT07191184 is actively recruiting participants. Contact the research team at catherine.lamouille@chru-strasbourg.fr for enrollment information.

Where is the NCT07191184 trial being conducted?

This trial is being conducted at Strasbourg, France.

Who is sponsoring the NCT07191184 clinical trial?

NCT07191184 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 12 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology